American Journal of Clinical Oncology-Cancer Clinical Trials

Papers
(The H4-Index of American Journal of Clinical Oncology-Cancer Clinical Trials is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody37
Treatment and Prevention of Brain Metastases in Small Cell Lung Cancer29
The Impact of COVID-19 on Patients With Cancer26
PARP Inhibitors in Newly Diagnosed and Recurrent Ovarian Cancer26
Angiosarcoma of the Breast24
Impact of Pain, Opioids, and the Mu-opioid Receptor on Progression and Survival in Patients With Newly Diagnosed Stage IV Pancreatic Cancer23
Impact of Use of Antibiotics on Response to Immune Checkpoint Inhibitors and Tumor Microenvironment19
Vaccination and Immune Checkpoint Inhibitors19
Early Palliative Care Is Associated With Reduced Emergency Department Utilization in Pancreatic Cancer19
ACR–ASTRO Practice Parameter for the Performance of Stereotactic Body Radiation Therapy18
Medical Cannabis in Cancer Patients18
Trends in Diagnosis and Treatment of Metastatic Cancer in the United States16
Comparison of FOLFIRINOX and Gemcitabine Plus Nab-paclitaxel for Treatment of Metastatic Pancreatic Cancer16
Breast and Cervical Cancer Screening Disparities in Transgender People15
Adjuvant Trastuzumab Emtansine (T-DM1) and Concurrent Radiotherapy for Residual Invasive HER2-positive Breast Cancer15
0.045300960540771